| ¿µ¹® | official name(=generic name) | ÇÑ±Û | ÀϹݸí |
|---|---|---|---|
| ¼³¸í | ¾àÀÇ À̸§À» ºÎ¸¦¶§ ÀϹݸí°ú ÀÌ¿¡ ¹ÝÇÏ´Â »óÇ¥¸í(brand name: trade name)ÀÌ ÀÖ´Ù. ÀϹݸíÀº ¾àÀÇ ¼ººÐ¿¡ µû¶ó ºÙÀÌ´Â À̸§À¸·Î ºñ·Ï »óÇ¥¸íÀº ´Þ¶óµµ ±× ÀϹݸíÀº ¸ðµÎ µ¿ÀÏÇÒ ¼ö ÀÖ´Ù. ¿¹¸¦ µé¾î ampicillin(Ç×»ýÁ¦ÀÇ ÀÏÁ¾)À̶ó´Â ÀÏ¹Ý¸í¿¡ ´ëÇØ °¢ ȸ»ç¿¡¼´Â ¸ðµÎ ÀÌ ¼ººÐ¿¡ µû¶ó ¾àÀ» ¸¸µéÁö¸¸, °íÀ¯ÇÑ Amcill, 0mnipen, Penbritin, Polycillin µîÀÇ °¢±â ´Ù¸¥ »óÇ¥¸¦ ºÙÀÌ°Ô µÈ´Ù. |
||
| ¿µ¹® | psychiatric symptom(s) | ÇÑ±Û | Á¤½ÅÁõ»ó |
|---|---|---|---|
| ¼³¸í | Á¤½Åº´¿¡ ƯÀÌÇÑ Áõ»óµé·Î ȯ°¢, ¸Á»ó, Çö½Ç°úÀÇ ±«¸®°¨, ±â¾ï·Â Àå¾Ö, »ç°íÀÇ Àå¾Ö µîÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù. ¢Âȯ°¢: ¿©·¯ °¡Áö Á¾·ù°¡ ÀÖÀ¸¸ç, Çê°ÍÀÌ º¸ÀÌ´Â °æ¿ì ȯ½Ã¶ó Çϰí Çê°ÍÀÌ µé¸®´Â °æ¿ì ȯû, ´À²¸Áö´Â °æ¿ì ȯÃËÀ̶ó ÇÔ. ´ë°³ Á¤½ÅºÐ¿º´È¯ÀÚ¿¡¼ ¸¹ÀÌ º¸À̳ª, ¾ËÄÝÁßµ¶ÀÚ µî¿¡¼µµ °ðÀß ³ªÅ¸³´Ù. Á¤»óÀο¡¼µµ º¸ÀÏ ¼ö ÀÖ´Ù. ¢Â¸Á»ó: Á¤»óÀûÀ¸·Î ÀÌÇØµÇÁö ¾Ê´Â »ý°¢À¸·Î ±× »ç¶÷ÀÇ »î°ú ±³À°È¯°æ¿¡ ºñÃß¾î µµÀúÈ÷ ³ª¿Ã ¼ö ¾ø´Â ¹ß»óÀ» ÀǹÌÇÑ´Ù. ¶ÇÇÑ ¾î¶² ¼³µæÀ̳ª, ÀÌÇØ·Îµµ °íÄ¥ ¼ö ¾ø´Â °æ¿ì¸¦ À̸¥´Ù. |
||
| ¿µ¹® | psychiatric disorder(s) | ÇÑ±Û | Á¤½ÅÁúȯ |
|---|---|---|---|
| ¼³¸í | Á¤½Å»óÅ¿¡ ÀÌ»óÀÌ ÀÖ´Â ÁúȯÀ¸·Î, Á¤½ÅºÐ¿º´, Á¤µ¿Àå¾Ö, ÀΰÝÀå¾Ö µîÀÌ ÀÖ´Ù. |
||
| APA | action potential amplitude; aldosterone-producing adenoma; Ambulatory Pediatric Association; America... |
|---|---|
| AOAC | Association of Official Agricultural Chemists |
| BPRS | brief psychiatric rating scale; brief psychiatric reacting scale |
| AAP | air at atmospheric pressure; American Academy of Pediatrics; American Academy of Pedodontics; Americ... |
| IPA | immunoperoxidase assay; incontinentia pigmenti achromians; independent physician or practice associa... |
| AOAC | Association of Official Analytical Chemists |
|---|---|
| JAMA | Journal of the American Medical Association |
| A.P.A. | American Psychiatric Association |
| NEJM | New England Journal of Medicine |
| BPRS | Brief Psychiatric Rating Scale |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
|---|---|
| medical missions, official | Travel by a group of physicians to a foreign country for the purpose of making a special study or of undertaking a special project of a short-term duration; not to be confused with missions and missionaries which covers permanent medical establishments and personnel maintained by religious organizations. (12 Dec 1998) |
| official | 1. Of or pertaining to an office or public trust; as, official duties, or routine. "That, in the official marks invested, you Anon do meet the senate." (Shak) 2. Derived from the proper office or officer, or from the proper authority; made or communicated by virtue of authority; as, an official statement or report. 3. <pharmacology> Approved by authority; sanctioned by the pharmacopoeia; appointed to be used in medicine; as, an official drug or preparation. Cf. Officinal. 4. Discharging an office or function. "The stomach and other parts official unto nutrition." (Sir T. Browne) Origin: L. Officialis: cf. F. Officiel. See Office, and cf. Official. Source: Websters Dictionary (01 Mar 1998) |
| official formula | A formula contained in the Pharmacopeia or the National Formulary. (05 Mar 2000) |
| egyptian | Pertaining to Egypt, in Africa. Egyptian bean. <botany> A medium-sized tree (Acacia vera). It is one of the chief sources of the best gum arabic. Origin: L. Aegyptius, Gr, fr. (L. Aegyptus) Egypt: cf. F. Egyptien. Cf. Gypsy. Source: Websters Dictionary (01 Mar 1998) |
| Egyptian haematuria | Infection with Schistosoma haematobium, the eggs of which invade the urinary tract, causing cystitis and haematuria, and possibly an increased likelihood of bladder cancer. Synonym: bladder schistosomiasis, Egyptian haematuria, endemic haematuria, urinary schistosomiasis. (05 Mar 2000) |
| Egyptian ophthalmia | <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness. It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt. The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts. Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery. Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China. The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness. The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented. International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach. Origin: Gr. Trachoma = roughness (07 May 1998) |
| Egyptian splenomegaly | Term sometimes used as a synonym for schistosomiasis mansoni, although hepatomegaly and fibrosis are more consistently found than is an enlarged spleen. (05 Mar 2000) |
| brief psychiatric rating scale | A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. (12 Dec 1998) |
| psychiatric | Pertaining to or within the purview of psychiatry. (18 Nov 1997) |
| psychiatric aides | Persons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department. (12 Dec 1998) |
| psychiatric department, hospital | Hospital department responsible for the organization and administration of psychiatric services. (12 Dec 1998) |
| psychiatric nursing | A specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient. (12 Dec 1998) |
| psychiatric somatic therapies | The biologic treatment of mental disorders (e.g., electroconvulsive therapy), in contrast with psychotherapy. (stone, american psychiatric glossary, 1988, p159) (12 Dec 1998) |
| psychiatric status rating scales | Standardised procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|